Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff

BACKGROUND: During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment. METHODS: As part of a study seeking to implement interim methadone without routine counsel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Shannon Gwin, Jester, Julia, Gryczynski, Jan, Whitter, Melanie, Fuller, Douglas, Halsted, Caroline, Schwartz, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580566/
https://www.ncbi.nlm.nih.gov/pubmed/37848970
http://dx.doi.org/10.1186/s13722-023-00417-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580566/
https://www.ncbi.nlm.nih.gov/pubmed/37848970
http://dx.doi.org/10.1186/s13722-023-00417-7

Ejemplares similares